Skip to main content
FinSpry Logo
FinSpry
URGN logo
URGN
(NASDAQ)
UroGen Pharma Ltd.
$42.50-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

UroGen Pharma (URGN) Stock Price & Financial Analysis

UroGen Pharma Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$41.25 - $42.69
52-Week High$43.93
52-Week Low$15.86
Open$41.42
Volume494.54K
Average Volume (3M)740.13K
Market Cap2.13B
Shares Outstanding50.18M
Price to Sales (P/S)15.18
Price to Book (P/B)-17.16
EV/EBITDA-19.16
Revenue (TTM)140.49M
Net Income (TTM)-133.22M
Free Cash Flow (TTM)-166.03M
EPS (TTM)$-2.73
Profit Margin-94.83%
Operating Margin-77.02%
50-Day MA$33.41
200-Day MA$24.38
52-Week Change127.76%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About UroGen Pharma

What is the current stock price for URGN?

As of the latest trading session, URGN stock trades at $42.50. The 52-week range is $15.86–$43.93, with a day range of $41.25–$42.69.

What is the P/E ratio for URGN?

The P/E ratio (Price-to-Earnings) for URGN is shown in the Key Statistics section. This valuation metric helps compare UroGen Pharma Ltd. to industry peers.

Does URGN pay dividends?

UroGen Pharma does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for URGN?

Based on 6 analysts, the consensus for URGN is Buy.

What is the market cap of URGN?

UroGen Pharma's market capitalization is $2.13B, classifying it as a mid-cap company. UroGen Pharma operates in the Healthcare sector within the Biotechnology industry.